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Abstract
Recent innovations in DNA nanofabrication allow the creation of intricately shaped nanostructures 
ideally suited for many biological applications. To advance the use of DNA nanotechnology for 
the controlled release of bioactive molecules, we report a general strategy that uses light to liberate 
encapsulated cargoes from DNA nanostructures with high spatiotemporal precision. Through the 
incorporation of a custom, photolabile cross-linker, we encapsulated cargoes ranging in size from 
small molecules to full-sized proteins within DNA nanocages and then released such cargoes upon 
brief exposure to light. This novel molecular uncaging technique offers a general approach for 
precisely releasing a large variety of bioactive molecules, allowing investigation into their 
mechanism of action, or finely tuned delivery with high temporal precision for broad biomedical 
and materials applications.
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Rapid advances in structural DNA nanotechnology allow the creation of intricately shaped 
nanostructures that can be functionalized with a high degree of control at precise 
locations.1–4 For example, DNA origami can be reliably and efficiently self-assembled by 
folding large, single stranded DNA with a set of specifically designed short oligonucleotide 
strands.5 This technique affords a tremendous amount of control over the size and shape of 
the nanostructure whose designs can now be assisted by well-developed software tools.6–8 
Molecularly programmed, static,9–11 or dynamic12–14 DNA architectures hold promise for 
applications in areas such as cell biology,15 NMR spectroscopy,16 super resolution 
microscopy,17 and nanotherapeutics,18 many of which would be advanced if DNA 
nanostructures were capable of releasing bound cargos at precise times.
Attempts to obtain controlled release from DNA origami nanostructures thus far have 
utilized two approaches through either noncovalent or covalent attachment of the cargo to 
origami. For example, the chemotherapy drug doxorubicin has been found to be able to 
noncovalently bind to DNA nano-structures through interactions with the DNA helices.19,20 
By controlling the DNA origami structure configuration, it was shown that doxorubicin 
release from the nanostructures could elicit a cytotoxic response in regular and drug-resistant 
cancer cells. Noncovalent attachment strategies however critically depend on a chemical’s 
ability to intercalate into DNA helices. This binding mechanism cannot be generalized to 
most chemicals, and the binding sites within an origami cannot be easily controlled spatially. 
Direct covalent attachment of cargo to DNA origami nanostructures can overcome most of 
these limitations. To covalently attach a cargo to DNA helices, short DNA strands can be 
designed to protrude at specific locations on the surface of the nanostructures, which can 
then bind to a variety of different chemical moieties including inorganic nanoparticles,21,22 
proteins,23 antibodies,18 and fluorophores.24 Placement of cleavable linkages within these 
DNA strands permits the release of the bound cargo in a highly controllable fashion. 
However, such strategies often leave a chemical remnant, the chemical group that connects 
the cargo to DNA strands25 on the molecules being released, which may compromise their 
native biological function, limiting this approach to applications where the bio-activity of the 
cargo is important. Here, we demonstrate a novel and general method that releases 
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chemically unaltered cargoes using brief pulses of light that can be broadly applied to a large 
variety of molecules.
We designed a novel, photolabile linker to append cargo molecules into the cavities of DNA 
nanostructures, so that light irradiation-induced breakage of the linker would allow the 
molecules to diffuse away from the protective cavity (Figure 1). This photolabile cross-
linker possesses an o-nitrobenzyl (o-NB) motif for photocleavage, an azido group for 
attachment to alkyne functionalized oligonucleotides, and an activated carbonate group for 
attachment to cargo molecules possessing a free amino functional group (Figure 1A). The 
linker is designed to release cargo upon photo cleavage in its original state with no chemical 
remnants remaining attached. Given the fact that most peptides, proteins, and bioactive 
compounds contain exposed amino residues, the cross-linker design is broadly applicable to 
attach many molecules to DNA nanostructures, beyond the examples described here.
We first synthesized this photolabile cross-linker using conventional organic synthesis 
techniques. Gram scale product was easily produced from inexpensive, commercially 
available starting materials (Scheme S1). This photolabile cross-linker was then reacted with 
cargo molecules including glutamate, bovine serum albumin (BSA), and biotin amine, and 
subsequently conjugated to oligonucleotides allowing the cargo to be incorporated into 
preassembled DNA origami through DNA base pairing (Scheme S2).
In parallel, we computationally designed a multilayered, brick-like nanocage structure with a 
well-defined cavity in its center, similar to those previously reported.6,20,26 The nanocage 
contains 14 addressable, single-stranded DNA extensions in its cavity, which are 
complementary to those presented on the activated cargo (Figure 1B–D). Nanostructures 
were then self-assembled in a single step by slowly cooling a heated mixture of the DNA 
components. Analysis of the assembly by agarose gel electrophoresis showed a single, 
dominant product band that migrated faster relative to the single stranded DNA starting 
material (m13 DNA), consistent with that generally observed for multilayered DNA origami 
structures (Figure 1C).9,21 Further examination with transmission electron microscopy 
(TEM) revealed properly assembled structures with the desired shape and a clearly visible 
central cavity (Figure 1D). The short single-stranded DNA extensions, however, were too 
small to be resolved using TEM. Purification of fully formed nano-structures from excess 
oligonucleotides or subsequent cargo molecules was accomplished using poly(ethylene 
glycol) precipitation.27
Fully assembled and purified DNA nanocages were then incubated with the activated cargo 
to attach them to the interior of the nanocage cavity. When positioned inside of the nano-
structure, the cargo is protected from the exterior environment and unable to bind to its 
native sites of action. Release from the cage was then achieved with light irradiation, which 
cleaved the photolabile bonds within the cross-linker (Figure 1E).
To first validate the photocleavage of our cross-linkers, we used it to conjugate an 
oligonucleotide to the small fluorescent molecule Oregon Green cadaverine (OG). We 
irradiated the compound with a low-power light source over time and quantified the degree 
of separation of OG from the oligonucleotide using HPLC (Figure 2A). We found that an 
Kohman et al. Page 3
Nano Lett. Author manuscript; available in PMC 2016 July 25.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
increasing duration of light exposure led to a larger fraction of free OG dye. After 11 s of 
low-powered light irradiation, 50% of OG was released. Nearly complete cleavage was 
achieved after 40 s of exposure, consistent with the time course for the cleavage of the o-NB 
motif within the cross-linker.28
We then loaded the activated OG into the cavities of the nanostructures by incubating the 
OG/DNA conjugate with preassembled nanocages. To quantify loading efficiency, we 
incorporated a nonlabile dye (Alexa Fluor 647N, AF647) for comparison by attaching it to a 
region on the nanostructure distal to the cavity (Figure 2B). UV absorbance spectra analysis 
of the product showed two distinct absorption peaks centered around 500 and 647 nm, 
corresponding to the two dyes used (Figure 2C, yellow trace). The ratio of the dye 
concentrations for OG versus AF647 was 7.4 to 1, suggesting that about half of the 14 DNA 
extensions on each cage designed to bind OG were bound, which is likely a representative 
loading capacity for small molecules of similar size.
To measure the efficiency of the light-induced release of OG from the nanocages, we 
irradiated the structures with a low powered lamp for 60 s, and then analyzed the absorbance 
spectra of the reaction solution after extensive sample dialysis of released free OG (Figure 
2B). We observed that the peak absorption at 500 nm corresponding to the photolabile OG 
dye was completely absent after irradiation, whereas the 647 nm absorption peak 
corresponding to the nonlabile AF647 remained (Figure 2C, blue trace). Together, these 
results demonstrate that our uncaging strategy can successfully release small molecular 
cargo from the DNA nanostructure upon brief low energy light irradiation.
We then explored the possibility of releasing large proteins from the nanocages, using 
bovine serum albumin (BSA) and streptavidin as examples that can be easily observed and 
analyzed using TEM. BSA was directly caged through the reaction of our cross-linker with 
the surface amino groups on the protein. Streptavidin was indirectly caged by attaching 
biotin-amine to the nanocage cavity and then subsequently mixing with the protein. TEM 
analysis of nanostructures at different orientations revealed clearly visible BSA and 
streptavidin proteins within the cavity of the DNA cage (Figure 3). None were seen tethered 
to the cage exterior. The number of DNA nanostructures with and without proteins was 
determined via particle counting of TEM images, and a loading efficiency of 93% for BSA 
and 71% for streptavidin was observed. After low power light irradiation for 60 s, we found 
only 19% of nanocages contained BSA, and 9% cages contained streptavidin, which 
corresponds to uncaging efficiencies of 79% for BSA and 87% for streptavidin. Together, 
these results demonstrate that full sized proteins can be effiectively encapsulated and 
uncaged with high efficiency.
To demonstrate that molecules released from the DNA nanocages retain their bioactivity, we 
tested uncaging of the small molecule glutamic acid, an excitatory neurotransmitter that has 
been shown to be successfully uncaged in numerous instances (Figure 4A).29–31 The 
bioactivity of the released glutamate from the nanocages was measured by glutamate 
mediated calcium changes in cultured neurons using real-time fluorescence imaging. 
Primary hippocampal neuron cultures were incubated with the intracellular calcium dye 
Fluo-4 and the glutamate-containing DNA nanocages. Before light illumination, little basal 
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calcium activity was observed in the nine-day-old cultures, consistent with the general 
activity patterns observed in neuron cultures of this age (Figure 4B and C).32 Immediately 
following a 1 ms light pulse illumination (240–400 nm), we observed an increase in 
intracellular calcium levels in 16.22% (N = 185 neurons, analyzed in two tests) (Figure 4C, 
Video S1). Activated cells exhibited heterogeneity in response amplitude with activation 
onsets ranged from 509 ms to 18.19 s after the light pulse, which could be due to difference 
in difiusion time from the releasing site to the cell surface, the concentration of released 
glutamic acid on a given cell, and intrinsic variability of cellular calcium responses (Figure 
4D). The fact that light irradiation was delivered for 1 ms suggests that uncaging can be 
performed with millisecond temporal resolution. In the absence of the DNA nanocages, no 
cells exhibited a change in calcium levels upon light illumination (N = 124 neurons, 
analyzed in two tests) (Figure 4B, Video S2). Together, these results demonstrate that DNA 
nanocages can be used to release functional bioactive molecules with millisecond temporal 
precision.
In conclusion, we describe a novel strategy to encapsulate bioactive molecules inside DNA 
nanostructures and release them using pulses of light. This strategy is realized through 
tagging DNA origami with a novel photolabile cross-linker that can be broadly used to 
encapsulate a large variety of molecules. With this cross-linker, a single, general chemical 
reaction scheme can be used to attach chemicals of interest to DNA origami through reacting 
with amino groups which are present on many biologically relevant compounds. This 
technique allows the release of cargo in its unaltered, bioactive state in contrast to existing 
labile conjugation chemistries, which often leave behind a chemical remnant that may 
interfere with the natural bioactivity of the cargo. This strategy was shown to be effective for 
a range of molecular sizes, from small molecules to full-sized proteins. Our nanocage design 
offers a high degree of addressability and customization, and future versions could be 
created that accommodate a larger variety of cargo molecules or cocktails of molecules in 
precise stoichiometries by controlling the shape and dimensions of the nanostructures as 
well as the sequences of the strands protruding from the cavity. Although light controlled 
uncaging techniques have been successful in releasing small molecules that rely on small, 
photochemical blocking chemical groups, our nanocaging platform could be easily designed 
to release many previously uncagable compounds and accelerate progress in understanding 
chemical receptor binding or controlled release of therapeutics.
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Figure 1. 
Design and creation of light-triggered, cargo-releasing nanocages. (A) Scheme of the 
chemical activation of a cargo molecule with the photolabile cross-linker and an 
oligonucleotide. (B) Depiction of the DNA nanostructure formation. The solid cylinders 
represent DNA helices as shown by the inset. (C) Agarose gel electrophoresis showing the 
high folding yield of the crude DNA nanocage sample. Lane L contains the 1-kb ladder, lane 
m13 contains the single stranded DNA starting material, and lane cage contains the crude 
reaction mixture. (D) TEM images of DNA nanocages. Scale bars are 200 and 25 nm, 
respectively. (E) Schematic depiction of the encapsulation of cargo, the photocleavage 
reaction, and subsequent cargo release.
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Figure 2. 
Light-triggered release of small molecules from nanocages. (A) Photolysis data showing 
increased irradiation duration results in an increase in the cleavage of Oregon Green/
oligonucleotides conjugate. (B) Schematic depiction of the dye uncaging experiment. DNA 
nanostructures remain in the microdialysis chamber, whereas small dyes are able to diffuse 
out. (C) Absorption spectra of a duel dye tagged nanocage before (yellow curve) and after 
light irradiation (blue curve).
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Figure 3. 
Light-triggered release of proteins, (A) streptavidin and (B) bovine serum albumin from 
nanocages. (i) Schematic depictions of the DNA nanocages with and without proteins. (ii) 
TEM images of nanocaged proteins before (left) and after (middle) irradiation with light. 
Scale bars are 25 nm. (iii) Graphs showing percentage of nanocages containing protein as 
determined by TEM image counting before and after light are shown on the right. Numbers 
in parentheses indicate the number of particles counted per condition.
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Figure 4. 
Light-triggered release of glutamate from DNA nanocages. (A) Schematic depiction of 
glutamate release from DNA nanocage using UV light at 240–400 nm and the subsequent 
activation of neurons by the freed glutamate. (B,C) Temporal derivative of the normalized 
fluorescence intensity indicating calcium concentration changes in the control group, 
neurons illuminated in the absence of nanocages (B, N = 124 neurons), and in the uncaging 
group, neurons illuminated in the presence of nanocages (C, N = 185 neurons). (D) 
Normalized fluorescence intensity indicating intracellular calcium activities of responsive 
cells in the uncaged group, aligned to light onset. Thick blue line indicates the mean, shaded 
gray indicates standard deviation, and red dots indicate the onset time (N = 30 neurons).
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